12:00 AM
 | 
Sep 13, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Protopam pralidoxime chloride regulatory update

FDA approved Baxter's Protopam pralidoxime chloride for use in pediatric patients to treat...

Read the full 43 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >